Cytogenotoxicity and inflammatory response in liver of rats exposed to different doses of cannabis nano emulsions
- PMID: 38494580
- DOI: 10.1007/s00204-024-03712-7
Cytogenotoxicity and inflammatory response in liver of rats exposed to different doses of cannabis nano emulsions
Abstract
Cannabis is the most used illicit substance for recreational purposes around the world. However, it has become increasingly common to witness the use of approved cannabis preparations for symptoms management in various diseases. The aim of this study was to investigate the effects of cannabis nano emulsion in the liver of Wistar rats, with different proportions of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). For this, a total of 40 male Wistar rats were distributed into 5 groups, as follows (n = 8 per group): Control: G1, Experimental group (G2): treated with cannabis nano emulsion (THC and CBD) at a dose of 2.5 mg/kg, Experimental group (G3): treated with cannabis nano emulsion (THC and CBD) at a dose of 5 mg/kg, Experimental group (G4): treated with cannabis nano emulsion (CBD) at a dose of 2.5 mg/kg; Experimental group (G5): treated with cannabis nano emulsion (CBD) at a dose of 5 mg/kg. Exposure to the nano emulsion was carried out for 21 days, once a day, orally (gavage). Our results showed that cannabis nano emulsions at higher doses (5 mg/kg), regardless of the composition, induced histopathologic changes in the liver (G3 and G5) in comparison with the control group. In line with that, placental glutathione S-transferase (GST-P) positive foci increased in both G3 and G5 (p < 0.05), as well as the immune expression of Ki-67, vascular endothelial growth factor (VEGF) and p53 (p < 0.05). Also, the nano emulsion intake induced an increase in the number of micronucleated hepatocytes in G5 (p < 0.05) whereas G3 showed an increase in binucleated cells (p < 0.05). As for metanuclear alterations, karyolysis and pyknosis had an increased frequency in G3 (p < 0.05). Taken together, the results show that intake of cannabis nano emulsion may induce degenerative changes and genotoxicity in the liver in higher doses, demonstrating a clear dose-response relationship.
Keywords: Cannabis; Cytotoxicity; Liver; Molecular alterations; Mutagenicity.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.Ther Drug Monit. 2005 Dec;27(6):799-810. doi: 10.1097/01.ftd.0000177223.19294.5c. Ther Drug Monit. 2005. PMID: 16306858 Clinical Trial.
-
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30661105 Clinical Trial.
-
Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol.Psychopharmacology (Berl). 2018 Nov;235(11):3289-3302. doi: 10.1007/s00213-018-5036-z. Epub 2018 Sep 20. Psychopharmacology (Berl). 2018. PMID: 30238130 Free PMC article.
-
Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.Front Biosci (Landmark Ed). 2022 Jul 25;27(8):228. doi: 10.31083/j.fbl2708228. Front Biosci (Landmark Ed). 2022. PMID: 36042166
-
Cannabidiol - therapeutic and legal aspects.Pharmazie. 2020 Oct 1;75(10):463-469. doi: 10.1691/ph.2020.0076. Pharmazie. 2020. PMID: 33305718 Review.
References
-
- Alamri ZZ (2018) The role of liver in metabolism: an updated review with physiological emphasis. Int J Basic Pharmacol 7(11):2271 - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous